Sharp Therapeutics Corp., a biology technology company, develops medicines specific for genetic diseases. It engages in the development of the CoreX biology, AlloChem chemistry, and Disco/Mine computational technologies to discover drugs that activate the protein altered by gene mutation. Sharp Therapeutics Corp. is based in Pittsburgh, Pennsylvania.